Trials / Not Yet Recruiting
Not Yet RecruitingNCT07395895
Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women
Effect of Metformin Iontophoresis Combined With Physical Therapy Rehabilitation on Knee Osteoarthritis in Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Badr University · Academic / Other
- Sex
- Female
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed as a randomized, double-blind, placebo-controlled clinical trial with two parallel groups. All participants will receive a standardized physical therapy rehabilitation program. Participants will be randomly allocated into either a study group receiving metformin iontophoresis or a control group receiving placebo iontophoresis. Both participants and outcome assessors will be blinded to group allocation.
Detailed description
The study population will consist of postmenopausal women diagnosed with knee osteoarthritis. Postmenopause is defined as the absence of menstruation for at least 12 consecutive months. Participants will be randomly assigned to either the study or control group using a computer-generated randomization sequence. Allocation concealment will be ensured using sealed opaque envelopes. Both participants and outcome assessors will be blinded to the treatment allocation. The physical therapist applying iontophoresis will not be involved in outcome assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin gel Iontophoresis | Metformin gel 2% Iontophoresis Combined with Physical Therapy Rehabilitation |
| DEVICE | Iontophoresis | Iontophoresis with neutral gel Combined with Physical Therapy Rehabilitation |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-04-15
- Completion
- 2026-05-01
- First posted
- 2026-02-09
- Last updated
- 2026-02-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07395895. Inclusion in this directory is not an endorsement.